Nonalcoholic steatosis/steatohepatitis is the most common cause for abnormal liver
chemistries. Apart from metabolic syndrome, drugs may also lead to development of …

We present the first description of amiodarone toxicity in the liver without phospholipidosis or
steatosis. In doing so, we will review the various effects of amiodarone toxicity in various …

A72-year-old Korean male was admitted because of sudden onset of abdominal distension.
He had been treated with amiodarone 200 mg, felodipine 5 mg, hydrochlorothiazide 25 mg …

The anti-arrhythmic agent amiodarone (AD) is associated with numerous adverse effects,
but serious liver disease is rare. The improved safety of administration of daily low doses of …

Amiodarone is used commonly in patients with cardiac diseases. Common side effects
include thyroid dysfunction and hepatic abnormalities. However, recently there has been …

A 63-year-old man presented with ascites after therapy with amiodarone, 200 mg orally once
per day for 22.5 months. A liver biopsy showed grade 3 chronic hepatitis and micronodular …

A few cases of alcohol-like chronic liver disease have recently been described in patients on
high daily doses of amiodarone (400–600 mg) for 5–24 months. We report here 3 cases in …

Background: Amiodarone is associated with varying degrees of hepatotoxicity. Aims: to
study the association between the presence of the metabolic syndrome or rightsided heart …

Background: Amiodarone-induced hepatotoxicity consists of mild liver test abnormalities and
rare cases of acute hepatitis and chronic hepatic lesions, and histologically resembles the …

Amiodarone is a widely used and effective long-term antiarrhythmic drug but with known
adverse effects. Prolonged oral administration of this drug has been implicated in numerous …